CAR-Immunotherapy PUBLISHED RESULTS

$450.00 | purchase

The CAR-Immunotherapy Results file contains 12 parameters for 123 full papers, and lists 38 case reports, published through 30 June 2020.

For each publication, the following topics are covered:

1. Trial ID with link
2. Publication ID with link
3. First/ Last author and year of report
4. Conditions treated
5. CAR target
6. Trial endpoints
7. Number of patients (enrolled, infused, evaluable)
8. Safety/ Adverse Events data
9. Efficacy and Persistence data
10. Durability of response time points
11. Were endpoints met?
12. Notes

Release 8 covers 161 publications through 30 June 2020.

• Total number of full papers increases by 15 from 108 to 123 publications.
• Total number of case reports increases by 6 from 32 to 38 publications.
• Total number of trials covered by these publications is 119.
• Among 15 full papers added: 14 in liquid and 1 in solid malignancies.
• Two of the publications are not liked to any clinical trial ID.

Release 7 covers 140 publications through 31 December 2019.

• Total number of full papers increases by 19 from 89 to 108 publications.
• Total number of case reports increases by 4 from 28 to 32 publications.
• 19 full papers added: 18 in liquid and 1 in solid malignancies
• Database covers 108 full papers about 105 trials

Release 6 covers publications through 30 June 2019.

• Total number of full papers increases by 8 from 81 to 89 publications.
• 8 full papers added: 6 in liquid and 2 in solid malignancies
• 4 clinical cases added
• one trial ID was not disclosed in publication
• one trial has two IDs

Release 5 covers publications up to 31 Dec. 2018.

• Total number of full papers increases by 12 from 69 to 81 publications.
• 9 trials added
• 9 publications added
• 3 publications IDs (PMID) added to existent data (new papers analyzed different aspects of the same trial)
• 2 clinical cases added

Release 4 covers publications up to 31 July 2018, including 9 full papers published in the first half of 2018.

• 2 trial results were updated for liquid malignancies with data from the most recent publications (2018)
• 4 more trials and 5 new full papers (one trial was not registered) were added to liquid malignancies
• 2 more trials and 2 new full papers were added to solid malignancies
• 4 more clinical case reports added (second tab)
• changes from the previous update are highlighted in green

Public samples: